SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007470
Filing Date
2024-05-09
Accepted
2024-05-09 07:35:47
Documents
104
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xoma-20240331x10q.htm   iXBRL 10-Q 2070106
2 EX-10.2 xoma-20240331xex10d2.htm EX-10.2 416220
3 EX-10.3 xoma-20240331xex10d3.htm EX-10.3 31536
4 EX-31.1 xoma-20240331xex31d1.htm EX-31.1 10583
5 EX-31.2 xoma-20240331xex31d2.htm EX-31.2 10612
6 EX-32.1 xoma-20240331xex32d1.htm EX-32.1 8693
  Complete submission text file 0001558370-24-007470.txt   11198363

Data Files

Seq Description Document Type Size
7 EX-101.SCH xoma-20240331.xsd EX-101.SCH 99418
8 EX-101.CAL xoma-20240331_cal.xml EX-101.CAL 60243
9 EX-101.DEF xoma-20240331_def.xml EX-101.DEF 507394
10 EX-101.LAB xoma-20240331_lab.xml EX-101.LAB 715989
11 EX-101.PRE xoma-20240331_pre.xml EX-101.PRE 694544
108 EXTRACTED XBRL INSTANCE DOCUMENT xoma-20240331x10q_htm.xml XML 1703798
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 24928597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)